Profund Advisors LLC Pfizer Inc Transaction History

Profund Advisors LLC

$2.65 Billion
Q2 2024

A detailed history of Profund Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Profund Advisors LLC holds 102,566 shares of PFE stock, worth $3.05 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

102,566

Previous 108,738 5.68%

Holding current value

$3.05 Million

Previous $3.02 Million 4.91%

% of portfolio

0.11%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $155,904 - $182,691	-6,172 Reduced 5.68%	102,566 $2.87 Million
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $155,391 - $178,439	-6,002 Reduced 5.23%	108,738 $3.02 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $258,399 - $335,632	9,889 Added 9.43%	114,740 $3.3 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $19,221 - $22,468	-599 Reduced 0.57%	104,851 $3.48 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $125,372 - $145,053	3,471 Added 3.4%	105,450 $3.87 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $27,848 - $36,254	-707 Reduced 0.69%	101,979 $4.16 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $2.11 Million - $2.76 Million	-50,551 Reduced 32.99%	102,686 $5.26 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $419,483 - $512,084	-9,586 Reduced 5.89%	153,237 $6.71 Million
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $807,016 - $956,868	-17,344 Reduced 9.63%	162,823 $8.54 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $1.03 Million - $1.27 Million	-22,436 Reduced 11.07%	180,167 $9.33 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $597,445 - $885,613	14,459 Added 7.69%	202,603 $12 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $294,061 - $377,746	-7,492 Reduced 3.83%	188,144 $8.09 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $101,122 - $114,554	2,816 Added 1.46%	195,636 $7.66 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $338,048 - $381,250	-10,094 Reduced 4.97%	192,820 $6.99 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $2.21 Million - $2.81 Million	66,080 Added 48.29%	202,914 $7.47 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $1.02 Million - $1.2 Million	-32,108 Reduced 19.01%	136,834 $5.02 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $1.23 Million - $1.5 Million	40,987 Added 32.03%	168,942 $5.52 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $1.5 Million - $2.15 Million	-55,545 Reduced 30.27%	127,955 $4.18 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $552,957 - $627,535	16,797 Added 10.08%	183,500 $7.19 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $2.88 Million - $3.74 Million	-88,718 Reduced 34.73%	166,703 $5.99 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $1.94 Million - $2.18 Million	-52,433 Reduced 17.03%	255,421 $11.1 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $2.23 Million - $2.45 Million	59,385 Added 23.9%	307,854 $13.1 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $2.11 Million - $2.41 Million	-54,883 Reduced 18.09%	248,469 $10.8 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $1.31 Million - $1.59 Million	38,063 Added 14.35%	303,352 $13.4 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $999,986 - $1.07 Million	-30,321 Reduced 10.26%	265,289 $9.63 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $439,911 - $510,357	-13,786 Reduced 4.46%	295,610 $10.5 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $2.67 Million - $2.84 Million	-80,411 Reduced 20.63%	309,396 $11.2 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $397,730 - $438,144	12,830 Added 3.4%	389,807 $13.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	376,977	376,977 $12.7 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Pfizer Inc Transaction History